Filtered By:
Condition: Polycystic Kidney Disease
Drug: Prograf

This page shows you your search results in order of date.

Order by Relevance | Date

Total 2 results found since Jan 2013.

The Case | Severe hypertension and hyperkalemia in a kidney transplant recipient
A 55-year-old man with a history of end-stage renal disease due to autosomal dominant polycystic kidney disease and bilateral nephrectomy without adrenalectomy underwent his first kidney transplantation after 6 years of hemodialysis. The patient had no history of donor-specific antibodies. The donor was described as a 69-year-old man with a history of active smoking and  aortic valvulopathy who died of a stroke without cardiac arrest or collapse. Maintenance immunosuppressive therapy consisted of low-dose tacrolimus and everolimus.
Source: Kidney International - July 19, 2019 Category: Urology & Nephrology Authors: Vincent Dupont, Charlotte Colosio, Marguerite Hureaux, Laetitia Mokri, Betoul Schvartz, Vincent Vuiblet, Antoine Braconnier, Rosa Vargas-Poussou, Philippe Rieu Tags: Make Your Diagnosis Source Type: research

Susceptibility to MELAS Exacerbations in a POLG1 Mutation Carrier (P5.264)
We describe a case of a 46-year-old woman who presented with expressive aphasia, disorientation, and inappropriate laughter. She notably had a history of bilateral sensorineural hearing loss and two stroke-like episodes in her 30s characterized by left hemiparesis. Over the preceding six months, she experienced rapidly progressive vision loss, headaches, and an episode of non-convulsive status epilepticus. Incidentally, she had undergone renal transplantation nine months earlier for autosomal dominant polycystic kidney disease, and was on immunosuppressive therapy with two calcineurin inhibitors—cyclosporine and tacr...
Source: Neurology - April 3, 2016 Category: Neurology Authors: Nadkarni, D., Restrepo, L. Tags: General Neurology: Genetics Source Type: research